{"name": "Avraham Pharmaceuticals",
 "permalink": "avraham-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/avraham-pharmaceuticals",
 "homepage_url": "http://www.avphar.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "yg@avphar.com",
 "phone_number": "972-8-932-4000",
 "description": "",
 "created_at": "Wed Jul 14 01:33:19 UTC 2010",
 "updated_at": "Fri Feb 22 03:32:11 UTC 2013",
 "overview": "\u003Cp\u003EAvraham Pharmaceuticals (\u201cAvraham\u201d) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer\u0026#8217;s disease, supporting the development of its lead product candidate, ladostigil.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       53],
      "assets/images/resized/0023/7552/237552v1-max-150x150.jpg"],
     [[250,
       89],
      "assets/images/resized/0023/7552/237552v1-max-250x250.jpg"],
     [[373,
       133],
      "assets/images/resized/0023/7552/237552v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "David",
      "last_name": "Warshawsky",
      "permalink": "david-warshawsky",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$17.7M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/avraham-pharmaceuticals-ltd-series-a-9m/",
    "source_description": "Avraham Pharmaceuticals, Ltd.: Series A $9M",
    "raised_amount": 9000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Yissum Research Development",
         "permalink": "yissum-research-development",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0025/9575/259575v1-max-150x150.png"],
             [[198,
               72],
              "assets/images/resized/0025/9575/259575v1-max-250x250.png"],
             [[198,
               72],
              "assets/images/resized/0025/9575/259575v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pontifax",
         "permalink": "pontifax",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clal Biotechnology",
         "permalink": "clal-biotechnology",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0005/0268/50268v2-max-150x150.png"],
             [[250,
               60],
              "assets/images/resized/0005/0268/50268v2-max-250x250.png"],
             [[305,
               74],
              "assets/images/resized/0005/0268/50268v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/11/avraham-pharmaceuticals-closes-3m-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Avraham Pharmaceuticals Closes $3M Financing",
    "raised_amount": 3000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 11,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Yissum Research Development",
         "permalink": "yissum-research-development",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0025/9575/259575v1-max-150x150.png"],
             [[198,
               72],
              "assets/images/resized/0025/9575/259575v1-max-250x250.png"],
             [[198,
               72],
              "assets/images/resized/0025/9575/259575v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clal Biotechnology",
         "permalink": "clal-biotechnology",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0005/0268/50268v2-max-150x150.png"],
             [[250,
               60],
              "assets/images/resized/0005/0268/50268v2-max-250x250.png"],
             [[305,
               74],
              "assets/images/resized/0005/0268/50268v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "private_equity",
    "source_url": "http://www.finsmes.com/2013/02/avraham-pharmaceuticals-raises-5-7m-funding.html",
    "source_description": "Avraham Pharmaceuticals Raises $ 5.7M in Funding",
    "raised_amount": 5700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 2,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Clal Biotechnology",
         "permalink": "clal-biotechnology",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0005/0268/50268v2-max-150x150.png"],
             [[250,
               60],
              "assets/images/resized/0005/0268/50268v2-max-250x250.png"],
             [[305,
               74],
              "assets/images/resized/0005/0268/50268v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Technion Research and Development Foundation",
         "permalink": "technion-research-and-development-foundation",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0023/7557/237557v1-max-150x150.jpg"],
             [[250,
               74],
              "assets/images/resized/0023/7557/237557v1-max-250x250.jpg"],
             [[388,
               115],
              "assets/images/resized/0023/7557/237557v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Yissum Research Development",
         "permalink": "yissum-research-development",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0025/9575/259575v1-max-150x150.png"],
             [[198,
               72],
              "assets/images/resized/0025/9575/259575v1-max-250x250.png"],
             [[198,
               72],
              "assets/images/resized/0025/9575/259575v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "42 Hayarkon st.",
    "address2": "Northern Industrial Zone",
    "zip_code": "81227",
    "city": "Yavneh",
    "state_code": null,
    "country_code": "ISR",
    "latitude": 31.9002186,
    "longitude": 34.7406165}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}